Investing Profile

Millie Ray

InvestorVC
Partner at The Column Group
Photo of Millie Ray, Partner at The Column Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
802 CONNECTIONS
Massachusetts Institute of Technology Network
545 CONNECTIONS
Massachusetts Institute of Technology Network
545 CONNECTIONS
Flagship Pioneering Network
86 CONNECTIONS
MIT Network
53 CONNECTIONS
cb
$100K - $5.0M
$1.5M
5
$600M
CompanyStageDateRound SizeTotal Raised
Casma Therapeutics
Series CNov 2022$46M
Series BSep 2020$50M
$160M
Co-investors: Cary Pfeffer (Third Rock Ventures), Hiromichi Kimura (TeamWork), Robert Tepper (Third Rock Ventures)
Hexagon Bio
Series BOct 2022$77M
Series UnknownSep 2021$61M
Series ASep 2020$47M
$190M
Co-investors: Alex Kolicich (8VC), David Goeddel (The Column Group), Dusan Perovic (Two Sigma Ventures), Jakob Loven (Nextech Invest)
Graduate Student and Post- Doctoral Researcher- Kingston Lab Massachusetts General HospitalPresent
Ebola Genomics team - Sabeti Lab Broad Institute of MIT and HarvardPresent
Fellow and Associate Flagship PioneeringPresent
Fellow and Associate Flagship Ventures - Venture LabsPresent
Business Associate Foghorn TherapeuticsPresent
Associate The Column GroupPresent
Principal The Column GroupPresent
General Partner The Column GroupPresent
Partner The Column GroupPresent
Massachusetts Institute of Technology S.B. S.B., Mathematics, Biology
MIT S.B., S.B. Mathematics, Biology
Massachusetts Institute of Technology S.B., S.B. Mathematics, Biology
Harvard University Doctor of Philosophy (PhD) Biological and Biomedical Sciences
Sign in with Google →
Sign in with Google →